- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 237/20 - Nitrogen atoms
Patent holdings for IPC class C07D 237/20
Total number of patents in this class: 310
10-year publication summary
|
16
|
22
|
12
|
16
|
21
|
20
|
16
|
19
|
20
|
14
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10612 |
25 |
| BASF SE | 21098 |
9 |
| Bayer AG | 3401 |
9 |
| Janssen Pharmaceutica N.V. | 3358 |
8 |
| Bayer Pharma AG | 1048 |
7 |
| Northwestern University | 3457 |
7 |
| Xenon Pharmaceuticals Inc. | 193 |
7 |
| Arcus Biosciences, Inc. | 144 |
6 |
| Nihon Nohyaku Co., Ltd. | 333 |
6 |
| Corteva Agriscience LLC | 2702 |
6 |
| Bristol-myers Squibb Company | 4826 |
5 |
| Deutsches Krebsforschungszentrum | 414 |
5 |
| Oryzon Genomics S.A. | 108 |
5 |
| Board of Regents, The University of Texas System | 5946 |
4 |
| Mitsubishi Tanabe Pharma Corporation | 560 |
4 |
| PTC Therapeutics, Inc. | 484 |
4 |
| UniQuest Pty Limited | 30 |
4 |
| Skyhawk Therapeutics, Inc. | 120 |
4 |
| Raze Therapeutics, Inc. | 18 |
4 |
| Centre National de La Recherche Scientifique | 10706 |
3 |
| Other owners | 178 |